PHQ-4 Scoring · Anxiety and Depression Screen (0-12, Subscale Cutoff ≥3)
The PHQ-4 (Patient Health Questionnaire-4) is a 4-item self-report screen for anxiety and depression that combines the PHQ-2 and the GAD-2, over the past 2 weeks. Totals run 0 to 12 (0-2 normal, 3-5 mild, 6-8 moderate, 9-12 severe), and a score of 3 or more on either 2-item subscale is a positive screen.
For professional reference, research, and education only. Not for diagnosis or medical advice.
PHQ-4 Score Interpreter
PHQ-4 Score Calculator
Enter each of the 4 items (0–3) to total them and see the band. Items are numbered, not reproduced: enter them from the form in front of you. Score the two depression and two anxiety items separately as well. Scoring aid only; it does not diagnose.
0 of 4 items entered — 4 still blank. The total can only rise, so treat the range as provisional.
Each item scores 0–3.
Enter a total score to see its range.
4 items, each 0 (not at all) to 3 (nearly every day) for the past 2 weeks; total 0 to 12. Also check each 2-item subscale: 3 or more on the depression items (PHQ-2) or the anxiety items (GAD-2) is a positive screen.
Total score Interpretation 9+ Severe9 to 12 is in the severe range of psychological distress. Check each subscale, give the full PHQ-9 and GAD-7 as indicated, and complete a clinical assessment. 6–8 Moderate6 to 8 is in the moderate range. At least one subscale is likely to be 3 or more; follow a positive subscale with the full PHQ-9 or GAD-7. 3–5 Mild3 to 5 is in the mild range. Check each subscale: 3 or more on either 2-item half is still a positive screen. 0–2 Normal0 to 2 is in the normal range, and neither subscale can reach the cutoff of 3. Total score categories (0-2 normal, 3-5 mild, 6-8 moderate, 9-12 severe) and the subscale cutoff of 3 per Kroenke et al. (2009), as reported by Materu et al. (2020).
The PHQ-4 (Patient Health Questionnaire-4) is a 4-item screen made of the 2-item PHQ-2 for depression and the 2-item GAD-2 for anxiety. Totals run 0 to 12, and each 2-item subscale has a cutoff of 3 [1] [3].
What does the PHQ-4 measure?
The PHQ-4 screens for depression and anxiety together, the two most common mental disorders in outpatient settings and the general population, which often co-occur [1]. It was built by combining two validated ultra-brief screens [1]:
- Depression (PHQ-2). Depressed mood and loss of interest or pleasure, the first two items of the PHQ-9. See the PHQ-2 page.
- Anxiety (GAD-2). Nervousness and uncontrollable worry, the first two items of the GAD-7 [3].
The total reflects overall psychological distress; the subscales point to which kind.
How do you give the PHQ-4?
- Who completes it. The client, on paper or a digital form.
- Time window. The past 2 weeks [3].
- Response scale. Each item is rated 0 (not at all), 1 (several days), 2 (more than half the days) or 3 (nearly every day) [3].
- Length. Four items, two per subscale.
- Permissions. Pfizer states that no permission is required to reproduce, translate, display or distribute the PHQ screeners [4]. Use the published form; the items are not reproduced on this page.
How do you score and interpret the PHQ-4?
- Add the four item ratings for a total from 0 to 12.
- Read the total as normal (0 to 2), mild (3 to 5), moderate (6 to 8) or severe (9 to 12) [3].
- Add the two depression items (PHQ-2, 0 to 6) and the two anxiety items (GAD-2, 0 to 6) separately. A subscale score of 3 or more is a positive screen for that half [3].
- Follow a positive depression subscale with the full PHQ-9, and a positive anxiety subscale with the full GAD-7. The PHQ-9 vs GAD-7 decision tree covers which to give first; the assessment comparison and the assessment tools guide set wider choices side by side.
A mild total can still hide a positive subscale: a total of 3 made of 3 on the anxiety items and 0 on the depression items is a positive anxiety screen.
Psychometric properties
- Original study. In 2,149 patients from 15 primary care clinics in the United States, factor analysis confirmed two separate factors, depression and anxiety, that explained 84% of the total variance. Higher PHQ-4 scores were strongly associated with functional impairment, disability days and health care use, and anxiety affected functional status independently of depression [1].
- General population. In a nationally representative German survey of 5,030 adults, confirmatory factor analysis supported the two-factor structure (RMSEA .027), which held across age and gender groups. A PHQ-2 score of 3 corresponded to the 93.4th percentile and a GAD-2 score of 3 to the 95.2nd percentile [2].
- Young women in Tanzania. In 2,426 out-of-school adolescent girls and young women aged 15 to 23, Cronbach's α for the PHQ-4 was 0.81 [3].
Limitations
- Screening, not diagnosis. A positive subscale identifies who needs the full PHQ-9 or GAD-7 and a clinical interview.
- No criterion interview in the norms. The German general population study did not include a diagnostic interview [2].
- Narrow content. Two items per condition cover only the core symptoms; it does not ask about suicidal thoughts, sleep, or physical symptoms.
- Total and subscales differ. The total severity ranges describe overall distress; a positive screen is defined per subscale.
- Self-report. Scores depend on recall of the past 2 weeks and willingness to disclose.
For individuals: This page is a clinical reference, not a diagnostic tool. If you have concerns about your own symptoms, bring this information to a qualified mental health professional.
Related
Billing
In the US, the PHQ-4 Scoring · Anxiety and Depression Screen (0-12, Subscale Cutoff ≥3) is usually billed under these CPT codes. Payer rules vary.
- Publisher
- Pfizer Inc.
- First published
- 2009
- Terms
- No permission is required to reproduce, translate, display or distribute it.
Assessments
- BDI-II Scoring Guide · Beck Depression Inventory
- CES-D: Center for Epidemiologic Studies Depression Scale
- CES-DC Scoring · Center for Epidemiologic Studies Depression Scale for Children
- Beck Anxiety Inventory (BAI) Scoring & Interpretation
- GAD-7 Scoring and Interpretation
- HAM-A: Hamilton Anxiety Rating Scale
Dot size shows how strongly each scale's condition is linked to this one in HiBoop's co-occurrence map.
FAQ
How is the PHQ-4 scored?
Each of the 4 items is rated 0 (not at all), 1 (several days), 2 (more than half the days) or 3 (nearly every day) for the past 2 weeks. Add all four for a total from 0 to 12. Add the two depression items for the PHQ-2 subscale and the two anxiety items for the GAD-2 subscale, each 0 to 6.
What is a positive PHQ-4 score?
A score of 3 or more on the two anxiety items (GAD-2) or on the two depression items (PHQ-2) is a positive screen for that subscale. The total is read as normal (0 to 2), mild (3 to 5), moderate (6 to 8) or severe (9 to 12) psychological distress.
What is the difference between the PHQ-4, PHQ-2 and GAD-2?
The PHQ-4 is the PHQ-2 depression screen and the GAD-2 anxiety screen given together. The PHQ-2 asks about depressed mood and loss of interest; the GAD-2 asks about nervousness and uncontrollable worry. Each half is scored on its own as well as in the total.
What should follow a positive PHQ-4?
Follow a positive depression subscale with the full PHQ-9, and a positive anxiety subscale with the full GAD-7, then a clinical interview. The PHQ-4 does not ask about suicidal thoughts, so ask directly when depression screens positive.
References
- 1.Kroenke K, Spitzer RL, Williams JB, Löwe B. An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics. 2009;50(6):613-21.
- 2.Löwe B, Wahl I, Rose M, Spitzer C, Glaesmer H, Wingenfeld K, Schneider A, Brähler E. A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord. 2010;122(1-2):86-95.
- 3.Materu J, Kuringe E, Nyato D, Galishi A, Mwanamsangu A, Katebalila M, Shao A, Changalucha J, Nnko S, Wambura M. The psychometric properties of PHQ-4 anxiety and depression screening scale among out of school adolescent girls and young women in Tanzania: a cross-sectional study. BMC Psychiatry. 2020;20(1):321.
- 4.Pfizer Inc. Patient Health Questionnaire (PHQ) Screeners: select a screener.
PHQ-4 © Pfizer Inc. No permission is required to reproduce, translate, display or distribute it.
HiBoop does not offer this scale. This page is reference material.